Switching from infliximab to once-weekly administration of 50 mg etanercept in resistant or intolerant patients with ankylosing spondylitis: Results of a fifty-four-week study

Fabrizio Cantini, Laura Niccoli, Maurizio Benucci, Daniela Chindamo, Carlotta Nannini, Ignazio Olivieri, Angela Padula, Carlo Salvarani

Research output: Contribution to journalArticlepeer-review

Original languageEnglish
Pages (from-to)812-816
Number of pages5
JournalArthritis Care and Research
Issue number5
Publication statusPublished - Oct 15 2006

ASJC Scopus subject areas

  • Rheumatology

Cite this